These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 30374347)

  • 21. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
    Park HE; Lee W; Shin MK; Shin SJ
    Front Immunol; 2021; 12():703060. PubMed ID: 34262571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Macrophage Response to
    Maphasa RE; Meyer M; Dube A
    Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells.
    Sia JK; Georgieva M; Rengarajan J
    J Immunol Res; 2015; 2015():747543. PubMed ID: 26258152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
    Mohareer K; Asalla S; Banerjee S
    Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages.
    Shen J; Fu Y; Liu F; Ning B; Jiang X
    Inflammation; 2023 Oct; 46(5):1749-1763. PubMed ID: 37212951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophils in Tuberculosis: Cell Biology, Cellular Networking and Multitasking in Host Defense.
    Borkute RR; Woelke S; Pei G; Dorhoi A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.
    Kiran D; Basaraba RJ
    Front Cell Infect Microbiol; 2021; 11():624607. PubMed ID: 33718271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunometabolism of Phagocytes During
    Kumar R; Singh P; Kolloli A; Shi L; Bushkin Y; Tyagi S; Subbian S
    Front Mol Biosci; 2019; 6():105. PubMed ID: 31681793
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Shim D; Kim H; Shin SJ
    Front Immunol; 2020; 11():910. PubMed ID: 32477367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stabilization of Hypoxia-Inducible Factor Promotes Antimicrobial Activity of Human Macrophages Against
    Zenk SF; Hauck S; Mayer D; Grieshober M; Stenger S
    Front Immunol; 2021; 12():678354. PubMed ID: 34149713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of host-directed therapies on the pathology of tuberculosis.
    Tsenova L; Singhal A
    J Pathol; 2020 Apr; 250(5):636-646. PubMed ID: 32108337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic Dynamics of Macrophage Immunometabolism during
    Shi L; Jiang Q; Bushkin Y; Subbian S; Tyagi S
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis.
    Saini S; Gangwar A; Sharma R
    Microbiol Res; 2023 Oct; 275():127466. PubMed ID: 37531813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis.
    Pyle CJ; Azad AK; Papp AC; Sadee W; Knoell DL; Schlesinger LS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120360
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammasome Activation and Function During Infection with Mycobacterium Tuberculosis.
    Ablasser A; Dorhoi A
    Curr Top Microbiol Immunol; 2016; 397():183-97. PubMed ID: 27460810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches.
    Mehta K; Spaink HP; Ottenhoff THM; van der Graaf PH; van Hasselt JGC
    Trends Pharmacol Sci; 2022 Apr; 43(4):293-304. PubMed ID: 34916092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated glycolytic metabolism of monocytes limits the generation of HIF1A-driven migratory dendritic cells in tuberculosis.
    Maio M; Barros J; Joly M; Vahlas Z; Marín Franco JL; Genoula M; Monard SC; Vecchione MB; Fuentes F; Gonzalez Polo V; Quiroga MF; Vermeulen M; Vu Manh TP; Argüello RJ; Inwentarz S; Musella R; Ciallella L; González Montaner P; Palmero D; Lugo Villarino G; Sasiain MDC; Neyrolles O; Vérollet C; Balboa L
    Elife; 2024 Jun; 12():. PubMed ID: 38922679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.